| 000 | 01768 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515004445.0 | ||
| 264 | 0 | _c20060112 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a0301-472X | ||
| 024 | 7 |
_a10.1016/j.exphem.2005.07.011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDanet-Desnoyers, Gwenn-Aël H | |
| 245 | 0 | 0 |
_aTelomerase vaccination has no detectable effect on SCID-repopulating and colony-forming activities in the bone marrow of cancer patients. _h[electronic resource] |
| 260 |
_bExperimental hematology _cNov 2005 |
||
| 300 |
_a1275-80 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _ximmunology |
| 650 | 0 | 4 |
_aBone Marrow _xdrug effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xtherapy |
| 650 | 0 | 4 |
_aCancer Vaccines _xadministration & dosage |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematopoietic Stem Cells _xdrug effects |
| 650 | 0 | 4 |
_aHistocompatibility Antigens Class I _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred NOD |
| 650 | 0 | 4 | _aMice, SCID |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xtherapy |
| 650 | 0 | 4 |
_aStem Cells _xdrug effects |
| 650 | 0 | 4 |
_aT-Lymphocytes, Cytotoxic _xdrug effects |
| 650 | 0 | 4 |
_aTelomerase _ximmunology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVaccination _xmethods |
| 700 | 1 | _aLuongo, Jennifer L | |
| 700 | 1 | _aBonnet, Dominique A | |
| 700 | 1 | _aDomchek, Susan M | |
| 700 | 1 | _aVonderheide, Robert H | |
| 773 | 0 |
_tExperimental hematology _gvol. 33 _gno. 11 _gp. 1275-80 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.exphem.2005.07.011 _zAvailable from publisher's website |
| 999 |
_c15889861 _d15889861 |
||